BioPro-RCMI-1505 trial: multicenter study evaluating the use of a biodegradable balloon for the treatment of intermediate risk prostate cancer by intensity modulated radiotherapy; study protocol

BACKGROUND: Prospective trials have demonstrated the advantage of dose-escalated radiotherapy for the biochemical and clinical control of intermediate risk prostate cancer. Dose escalation improves outcomes but increases risks of urinary and bowel toxicity. Recently the contribution of “spacers” pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasquier, David, Bogart, Emilie, Bonodeau, François, Lacornerie, Thomas, Lartigau, Eric, Latorzeff, Igor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956854/
https://www.ncbi.nlm.nih.gov/pubmed/29769060
http://dx.doi.org/10.1186/s12885-018-4492-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956854/
https://www.ncbi.nlm.nih.gov/pubmed/29769060
http://dx.doi.org/10.1186/s12885-018-4492-5

Ejemplares similares